PHARMING GROUP
Identification
Symbol
PHARM
ISIN code
NL0000377018
Exchange / Market
Euronext
Trading location
Amsterdam
Products family
Stocks
Market organization
Euronext-LocalSecurities
ICB
Biotechnology
Activity description
Pharming Group specializes in the development of innovative products for the treatment of genetic disorders, specialty products for surgical indications, and nutritional products. The group's technologies include innovative platforms for the production of protein therapeutics, technology and processes for the purification and formulation of these products, as well as technology in the field of DNA repair (DNAge). Net sales break down by type of revenues into grants (69.4%) and licence fees (30.6%).
Website address
www.pharming.com
Issuer website
www.pharming.com
Operation
IPO date
Do. 27/05/2010
IPO type
Initial Public offering
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure
OFFER SHARES